Ocugen (OCGN) Return on Capital Employed Growth (5y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Ocugen | 452.01 Mn | 452.01 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15,737.00 |
| Dec 31, 2025 | -12,405.00 |
| Sep 30, 2025 | -4,887.00 |
| Jun 30, 2025 | -501.00 |
| Mar 31, 2025 | 1,699.00 |
| Dec 31, 2024 | -1,783.00 |
| Sep 30, 2024 | -21,859.00 |
| Jun 30, 2024 | 243.00 |
| Mar 31, 2024 | 17,769.00 |
| Dec 31, 2023 | -41,327.00 |
| Sep 30, 2023 | 41,101.00 |
| Jun 30, 2023 | 24,961.00 |
| Mar 31, 2023 | 19,596.00 |
| Dec 31, 2022 | 15,302.00 |
| Sep 30, 2022 | 8,559.00 |
| Jun 30, 2022 | 7,383.00 |
| Mar 31, 2022 | 4,029.00 |
| Dec 31, 2021 | 3,267.00 |
| Sep 30, 2021 | 8,227.00 |
| Jun 30, 2021 | 12,124.00 |
| Mar 31, 2021 | 5,180.00 |
| Dec 31, 2020 | -1,289.00 |
| Sep 30, 2020 | -5,019.00 |
| Jun 30, 2020 | -5,712.00 |
| Mar 31, 2020 | -5,473.00 |